| mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-05 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-05 |
| mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-05 |
| mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
4e-05 |
| mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
4e-05 |
| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-05 |
| mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-05 |